These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 29456071

  • 21. Low performance of Policimbac® broth microdilution in determining polymyxin B MIC for Klebsiella pneumoniae.
    Rocha NC, Lopes JM, Russi KL, Palmeiro JK, Girardello R.
    Front Cell Infect Microbiol; 2023; 13():1139784. PubMed ID: 37325517
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
    Matuschek E, Åhman J, Webster C, Kahlmeter G.
    Clin Microbiol Infect; 2018 Aug; 24(8):865-870. PubMed ID: 29221995
    [Abstract] [Full Text] [Related]

  • 23. Can carbapenem-resistant enterobacteriaceae susceptibility results obtained from surveillance cultures predict the susceptibility of a clinical carbapenem-resistant enterobacteriaceae?
    Perez LR, Rodrigues D, Dias C.
    Am J Infect Control; 2016 Aug 01; 44(8):953-5. PubMed ID: 27021509
    [Abstract] [Full Text] [Related]

  • 24. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y, Zhang Q, Wen L, Chen J.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0015221. PubMed ID: 34704782
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L, Fazeli H, Moghim S, Nasr Isfahani B.
    Cell Mol Biol (Noisy-le-grand); 2018 Jan 31; 64(1):70-74. PubMed ID: 29412797
    [Abstract] [Full Text] [Related]

  • 27. Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Tansarli GS, Papaparaskevas J, Balaska M, Samarkos M, Pantazatou A, Markogiannakis A, Mantzourani M, Polonyfi K, Daikos GL.
    Int J Antimicrob Agents; 2018 Sep 31; 52(3):397-403. PubMed ID: 29960007
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
    Malchione MD, Torres LM, Hartley DM, Koch M, Goodman JL.
    Int J Antimicrob Agents; 2019 Oct 31; 54(4):381-399. PubMed ID: 31369812
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Performance of different methods for testing polymyxin B: comparison of broth microdilution, agar dilution and MIC test strip in mcr-1 positive and negative Escherichia coli.
    Wang Y, Berglund B, Zhu Y, Luo Q, Xiao Y.
    Lett Appl Microbiol; 2021 Aug 31; 73(2):197-205. PubMed ID: 33904164
    [Abstract] [Full Text] [Related]

  • 33. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene mcr-1 in CRE in a Hospital in Henan, China.
    Li Y, Sun QL, Shen Y, Zhang Y, Yang JW, Shu LB, Zhou HW, Wang Y, Wang B, Zhang R, Wang S, Shen Z.
    J Clin Microbiol; 2018 Apr 31; 56(4):. PubMed ID: 29386265
    [Abstract] [Full Text] [Related]

  • 34. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Tanfous FB, Raddaoui A, Chebbi Y, Achour W.
    Int J Antimicrob Agents; 2018 Dec 31; 52(6):861-865. PubMed ID: 30176353
    [Abstract] [Full Text] [Related]

  • 35. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Vieceli T, Henrique LR, Rech TH, Zavascki AP.
    J Infect Chemother; 2024 Jul 31; 30(7):621-625. PubMed ID: 38244722
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
    Vasoo S.
    J Clin Microbiol; 2017 Sep 31; 55(9):2573-2582. PubMed ID: 28724555
    [Abstract] [Full Text] [Related]

  • 37. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, Li W, Zhang X, Liao K, Man S, Wang S, Wen H, Li B, Guo Z, Tian J, Pei F, Liu L, Zhang L, Zou C, Hu T, Cai J, Yang H, Huang J, Jia X, Huang W, Cao B, Wang H.
    Antimicrob Agents Chemother; 2018 Feb 31; 62(2):. PubMed ID: 29203488
    [Abstract] [Full Text] [Related]

  • 38. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ, Karaaslan E.
    Infect Dis (Lond); 2019 Sep 31; 51(9):676-682. PubMed ID: 31298061
    [Abstract] [Full Text] [Related]

  • 39. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae.
    Jayol A, Nordmann P, Poirel L, Dubois V.
    J Antimicrob Chemother; 2018 Feb 01; 73(2):542-544. PubMed ID: 29165563
    [No Abstract] [Full Text] [Related]

  • 40. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS, Rhomberg PR, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2015 Dec 01; 83(4):379-81. PubMed ID: 26415906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.